v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 1,025 $ 689
Restricted cash and cash equivalents (Note 16) 2 63
Accounts receivable (Note 3) 158 196
Inventory, net (Note 5) 244 278
Derivative instruments (Notes 2 and 11) 33 56
Other current assets 47 67
Total current assets 1,509 1,349
Property, plant and equipment, net (Note 7) 7,499 7,546
Nuclear decommissioning trust funds (Notes 6 and 11) 1,869 1,900
Derivative instruments (Notes 2 and 11) 10 4
Other noncurrent assets 106 106
Total Assets 10,993 10,905
Liabilities and Equity    
Long-term debt, due within one year (Notes 10 and 11) 29 29
Accrued interest 126 60
Accounts payable and other accrued liabilities 248 281
Derivative instruments (Notes 2 and 11) 250 101
Stock-based compensation liabilities (Note 13) 477 501
Other current liabilities 80 78
Total current liabilities 1,210 1,050
Long-term debt (Notes 10 and 11) 6,778 6,782
Derivative instruments (Notes 2 and 11) 49 67
Postretirement benefit obligations (Note 12) 221 229
Asset retirement obligations and accrued environmental costs (Note 8) 496 494
Deferred income taxes 487 486
Acquired fuel supply contract liabilities 633 662
Other noncurrent liabilities 46 42
Total Liabilities 9,920 9,812
Commitments and Contingencies (Note 9)
Stockholders' Equity (Note 15)    
Common stock ($0.001 par value, 350,000,000 shares authorized) [1] 0 0
Additional paid-in capital 1,722 1,709
Accumulated retained earnings (deficit) (638) (612)
Accumulated other comprehensive income (loss) (11) (4)
Total Stockholders' Equity 1,073 1,093
Total Liabilities and Stockholders' Equity $ 10,993 $ 10,905
[1]
(a)45,395,007 and 45,687,828 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively.